It has been marketed as a non-opioid in Canada for a decade – a decision Health Canada could rescind as a new report reveals a 30-per-cent rise in prescriptions in four years
It has been marketed as a non-opioid in Canada for a decade – a decision Health Canada could rescind as a new report reveals a 30-per-cent rise in prescriptions in four years
